NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ConcertAI

ConcertAI

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.concertai.com/

Last Round

Series C

Mar 29, 2022

Est. Valuation

$1.9B

Total Funding Raised

$300M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

ConcertAI is a healthcare technology company that provides enterprise AI and real-world data (RWD) solutions to accelerate clinical research, improve clinical trial efficiency, and enhance patient outcomes in oncology and other complex diseases.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Clinical Trials, Medical AI, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

oncology intelligencereal-world evidenceRWEclinical trial matchingclinical decision supportoncology datareal-world dataRWDprecision medicinedata as a serviceDaaShealthcare analyticsdigital trial optimizationAI copilothealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ConcertAI Comparables

Compare ConcertAI with similar companies based on industry and business-model similarity.

ConcertAI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Roche Holding
81%
Verana Health
81%
Paradigm Health
80%

ConcertAI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 29, 2022
Series BJan 13, 2020

Key People

Founding team and executive leadership

Jeff Elton

Vice Chairman & Former Founding CEO

Founding Team

Michael Myshrall

Chief Financial Officer (CFO) Life Sciences Generative Agentic Artificial Intelligence AI

Executive Team

ConcertAI Investors

Notable investors and investment history

ConcertAI investors
InvestorRounds
Maverick VenturesSeries B
Sixth Street PartnersSeries C
Declaration PartnersSeries B
Sixth Street GrowthSeries C
AB Private Credit InvestorsSeries B
SymphonyAI GroupSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 10, 2026

    CancerLinQ is now part of ConcertAI.

  • Mar 1, 2026

    Launched Precision Trials, a SaaS platform for clinical trial execution.

ConcertAI Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ConcertAI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ConcertAI's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range840
Year Founded2018
Last FundingMar 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.